U.S. Communications Stock News

The Morning Bull - US Market Morning Update Monday, Oct, 27 2025 US stock futures are pointing higher ahead of the open, with investors cheering early momentum in trade talks between the US and China. Hopes that a deal is within reach have dialed back trade tensions and added optimism to markets, even as questions linger about inflation and how much relief lower rates might provide. This has prompted investors to weigh whether upbeat economic activity can overcome ongoing concerns about the...

Immix Biopharma, Inc. ( NASDAQ:IMMX ) insiders who purchased shares in the last 12 months were richly rewarded last...

In recent days, Churchill Capital Corp X saw a surge in bullish options activity, as 8,562 call contracts traded, double the expected volume, and implied volatility spiked. This unusually low Put/Call ratio of 0.14 and concentrated action in November call options highlight significant optimism among options traders regarding the company's outlook. With the spotlight on heightened call trading, we’ll explore how shifting market sentiment may influence Churchill Capital Corp X’s investment...

Helix Energy Solutions Group posted its highest quarterly revenue and best EBITDA figure in over a decade. This reflects real progress across key businesses and has led to an upbeat upgrade to management’s full-year 2025 financial outlook. See our latest analysis for Helix Energy Solutions Group. Helix Energy Solutions Group’s stock has been on a rollercoaster this year, but signs of renewed momentum are clear. The share price climbed 12% over the past 90 days after a dip earlier in the year,...

In 2025, Quantum Corporation announced it could not timely file its annual financial report due to accounting reviews, later disclosing material weaknesses in internal controls that required restatement of its financial statements, and its CEO resigned after just five months. This series of events has resulted in multiple securities fraud class action lawsuits from investors alleging improper revenue recognition and misleading statements, heightening scrutiny of the company's financial...

Hotel101 Global Holdings (NasdaqCM:HBNB) saw its shares climb over 16% at the close, extending its gains for the month to more than 52%. Investors have been paying close attention to the stock’s recent momentum. See our latest analysis for Hotel101 Global Holdings. After a rocky start to the year, Hotel101 Global Holdings is beginning to catch investors’ attention thanks to a rapid turnaround in share price momentum. The past month’s 52% share price return is a bright spot, a notable contrast...

Obook Holdings (OWLS) has shown some movement lately, and investors may be taking a closer look at the company based on its recent stock performance. Shares closed at $12.60, which is an increase of nearly 18% in the last trading session. See our latest analysis for Obook Holdings. Obook Holdings’ one-day share price return of 17.98% stands out after a tough year. However, this rebound comes on the heels of a steep 77.32% decline in the year-to-date share price return, which shows momentum...

Thermon Group Holdings' (NYSE:THR) stock is up by a considerable 6.8% over the past week. We wonder if and what role...

IES Holdings, Inc. ( NASDAQ:IESC ), might not be a large cap stock, but it saw a significant share price rise of 42% in...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

Over the past year, many Sanmina Corporation ( NASDAQ:SANM ) insiders sold a significant stake in the company which may...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...

We feel now is a pretty good time to analyse LifeStance Health Group, Inc.'s ( NASDAQ:LFST ) business as it appears the...

On October 22, 2025, DataVault AI, Inc. and Wellgistics Health, Inc. announced a non-binding letter of intent to integrate manufacturer-to-patient blockchain-enabled smart contracts into Wellgistics' prescription drug infrastructure, aiming to fully digitize tracking from script to fulfillment across more than 6,500 pharmacies nationwide. A unique aspect of this partnership is its focus on leveraging AI agents and digital routing tools to optimize prescription drug services while enhancing...

Thinking about what to do with TKO Group Holdings stock? If you own shares or are sizing up an entry, you’re probably weighing not only its impressive run but also wondering whether there is real value left or just excitement. TKO has certainly been hard to ignore. The stock has surged 63.6% over the past year, and it is up 30.9% year-to-date, showing strength most markets would envy. Even after a recent dip of 1.3% in the last week and a 6.1% slide over the last month, it is clear that the...

If you’ve found yourself eyeing Graham Holdings after its most recent moves, you’re not alone. Whether you’re considering holding, trimming, or jumping in fresh, the stock’s behavior lately has gotten plenty of investors talking. Despite facing a pullback of 13.7% over the last 30 days, which might have rattled less seasoned hands, Graham Holdings is still up an impressive 18.1% year to date and 33.8% over the past year. Step back further, and you see gains of 67.4% across three years and...

Ventyx Biosciences recently announced positive topline results from its Phase 2 clinical trial of VTX3232, showing significant reductions in key inflammatory biomarkers such as hsCRP and IL-6 in patients with obesity and cardiovascular risk factors. An interesting insight from the study is that VTX3232 achieved a robust safety and tolerability profile, both as a standalone therapy and in combination with semaglutide, highlighting its potential as a new oral anti-inflammatory option in...

If you’ve been eyeing CECO Environmental and wondering whether it’s time to get in, stay patient, or take wins off the table, you’re not alone. This stock has been quietly (and not so quietly) rewarding attentive investors with some eye-popping returns. Just check out the numbers: up 6.7% over the past week, 5.9% in the last month, and an astonishing 66.1% so far this year. Zoom out further, and the gains are even more impressive: nearly 95% for the past year and a staggering 637% over the...

Paul Mueller (MUEL) posted a noteworthy turnaround in its recent earnings, swinging to profitability over the past year after a stretch of losses. Earnings have accelerated at an average annual rate of 41.3% over the last five years, and the company’s net profit margin has expanded as profitability returned. The latest data points to attractive value with shares trading below estimated fair value, but investors should keep an eye on the high proportion of non-cash earnings when weighing the...

Bullish momentum is building around Churchill Capital Corp X (CCCX) as options traders pile into call contracts. Volumes have doubled the norm and implied volatility is spiking. The extremely low Put/Call Ratio suggests that optimism is widespread. See our latest analysis for Churchill Capital Corp X. After a quiet start to the year, Churchill Capital Corp X’s share price has climbed significantly in recent weeks, notching a 51.8% gain over the past month and doubling since the beginning of...

Core Scientific (CORZ) extended its streak of unprofitability this quarter, with net losses having grown at an average rate of 23.1% per year over the past five years. Looking ahead, analysts forecast an 83.98% annual growth in earnings and expect the company to achieve profitability within three years, while revenue is projected to expand at 36.3% per year, well above the US market average. Despite these optimistic growth projections, Core Scientific’s net profit margin has yet to show...

World Kinect (NYSE:WKC) remains unprofitable, with losses deepening at an average rate of 45.7% per year over the last five years and no improvement in its net profit margin this year. Revenue is forecast to edge down slightly by 0.01% per year in the near term, but the major storyline is an expected earnings turnaround. Analysts see profits growing by 125.91% per year, with the company potentially returning to profitability within three years, an outlook that stands out in the sector. See...